Michelle Dipp

Michelle Dipp, MD PhD is the co-founder and managing partner of Biospring Partners, a private equity and venture capital firm that invests in life sciences technology.

Michelle has at least ten years of experience in private equity and venture capital ‒ a career she started after completing her medical training. She also served as managing director at General Atlantic, general partner of Longwood Fund, and SVP of the Center of Excellence for External Drug Discovery (CEEDD) for GlaxoSmithKline.

She also boasts a Bachelor of Medicine and a Bachelor of Surgery from the University of Oxford Medical School. Moreover, she has a Doctor’s degree of Philosophy in Human Physiology from the University of Oxford.

Aside from being a life science investor for Biospring Partners, Michelle Dipp serves on the Board of Abzena.

You can check Michelle Dipp's investment history and timeline by visiting this website - https://michelledippinvestments.com/. Michelle also started her scholarship program for SY 2022-2023 for STEM college students (Freshman to Senior). Interested applicants may apply by visiting this website - https://michelledippscholarship.org/.